Alisha Stone has a BA in psychology and is dedicated to improving the lives of others living with chronic illnesses.

    This Drug is the Best and Worst News for Cystic Fibrosis
    This CF drug is good news for health... and also awful news financially.

    This Drug is the Best and Worst News for Cystic Fibrosis

    Not long ago, Vertex Pharmaceuticals scored a big one for their investors—the European Commission has approved the use of ORKAMBI® (lumacaftor/ivacaftor), for the treatment of cystic fibrosis. This breakthrough treatment will be used…

    Continue Reading This Drug is the Best and Worst News for Cystic Fibrosis
    How This Young Woman’s Double D’s Are Changing the World
    Disease and Depression. What this woman with EDS can teach all of us in the rare disease community.

    How This Young Woman’s Double D’s Are Changing the World

    Double D's. And not the good kind. Disease and Depression. All too often, after being diagnosed with a chronic illness, patients just give up. They withdraw. They stop trying. They…

    Continue Reading How This Young Woman’s Double D’s Are Changing the World
    How and Why You Should Get Big Money for HoFH Medication
    The PAF is increasing its efforts to fund co-pays for those suffering from HoFH.

    How and Why You Should Get Big Money for HoFH Medication

    If you or your loved one is living with homozygous familial hypercholesterolemia (HoFH), you’re going to be thrilled with this news--and you deserve it, too! The Patient Advocate Foundation (PAF) just announced on November 2nd,…

    Continue Reading How and Why You Should Get Big Money for HoFH Medication